Divi Rao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Divi Rao has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Gary L. Ellison
Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services , Bethesda, MD, USA
1 shared publication - Naoko Ishibe Simonds
Scientific Consulting Group, Inc., Gaithersburg, Maryland
1 shared publication - Tram Kim Lam
Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health , Rockville, MD
1 shared publication
Latest Publications
- 28 February 2025
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 194 (6) , 1485-1495
Allostatic load and cancer risk, progression, and mortality in epidemiologic studies
The current body of evidence from both preclinical and epidemiologic studies suggests that cumulative stress may play a role in carcinogenesis; however, few studies on human populations have examined allostatic load (AL) as it relates to cancer risk, progression, and mortality. In this commentary, we discuss the use and value of AL as a measure to assess exposure to stress for cancer epidemiologic studies, describe the existing evidence between AL and sources of cancer-related environmental stressors, and summarize the existing epidemiologic studies on AL and cancer risk, progression, and mortality. We also outline several knowledge gaps and what steps should be considered to advance research on the role of AL and cancer risk, progression, and mortality in human populations.
- 28 February 2025
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 194 (6) , 1485-1495
Allostatic load and cancer risk, progression, and mortality in epidemiologic studies
The current body of evidence from both preclinical and epidemiologic studies suggests that cumulative stress may play a role in carcinogenesis; however, few studies on human populations have examined allostatic load (AL) as it relates to cancer risk, progression, and mortality. In this commentary, we discuss the use and value of AL as a measure to assess exposure to stress for cancer epidemiologic studies, describe the existing evidence between AL and sources of cancer-related environmental stressors, and summarize the existing epidemiologic studies on AL and cancer risk, progression, and mortality. We also outline several knowledge gaps and what steps should be considered to advance research on the role of AL and cancer risk, progression, and mortality in human populations.